| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0960-894X(98)00287-X |
| P698 | PubMed publication ID | 9873412 |
| P2093 | author name string | Kwon CH | |
| Moon KY | |||
| P2860 | cites work | Preclinical evaluation of toxicity and therapeutic efficacy of a stabilized cytostatic metabolite of cyclophosphamide (ASTA Z 7557, INN mafosfamide) | Q70589453 |
| Experimental toxicology of ASTA Z 7557 (INN mafosfamide) | Q70589457 | ||
| Comparative effects of ASTA Z 7557 (INN mafosfamide) and cyclophosphamide on hematopoiesis in mice | Q70589461 | ||
| Studies on the urotoxicity of oxazaphosphorine cytostatics and its prevention--III. Profile of action of sodium 2-mercaptoethane sulfonate (mesna) | Q71645347 | ||
| Cyclophosphamide cystitis—Identification of acrolein as the causative agent | Q28327805 | ||
| Phase-I study of mafosfamide-cyclohexylamine (ASTA-Z-7557, NSC 345 842) and limited phase-I data on mafosfamide-lysine | Q36500339 | ||
| Chemical characterization of ASTA Z 7557 (INN mafosfamide, CIS-4-sulfoethylthio-cyclophosphamide), a stable derivative of 4-hydroxy-cyclophosphamide | Q36606835 | ||
| Chemically stable N-methyl-4-(alkylthio)cyclophosphamide derivatives as prodrugs of 4-hydroxycyclophosphamide | Q38531856 | ||
| Chemically stable, lipophilic prodrugs of phosphoramide mustard as potential anticancer agents | Q38534100 | ||
| Metabolism of oxazaphosphorines | Q39649226 | ||
| Prevention of cyclophosphamide-induced carcinogenesis in the urinary bladder of rats by administration of mesna | Q42248658 | ||
| Cocarcinogenic and tumor-promoting capabilities of anthralin | Q42805466 | ||
| Influence of mesna and cysteine on the systemic toxicity and therapeutic efficacy of activated cyclophosphamide | Q44054408 | ||
| Effects of N-substitution on the activation mechanisms of 4-hydroxycyclophosphamide analogues. | Q54107375 | ||
| Antineoplastic activity of ASTA Z 7557 (NSC-345842, INN mafosfamide) on transplantable murine tumors. | Q54483151 | ||
| Isolation and mass spectral identification of blood metabolities of cyclophosphamide: Evidence for phosphoramide mustard as the biologically active metabolite | Q66931110 | ||
| Activation mechanisms of mafosfamide and the role of thiols in cyclophosphamide metabolism | Q69729345 | ||
| Studies on the toxicity of cyclophosphamide in combination with mesna in vitro and in vivo | Q70451185 | ||
| Comparative in vitro cytotoxicity of cyclophosphamide, its major active metabolites and the new oxazaphosphorine ASTA Z 7557 (INN mafosfamide) | Q70589430 | ||
| A comparative study of therapeutic activity, myelotoxicity and DNA damage in the bone marrow of mice after cyclophosphamide and ASTA Z 7557 (INN mafosfamide) | Q70589449 | ||
| P433 | issue | 13 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1673-1678 | |
| P577 | publication date | 1998-07-01 | |
| P1433 | published in | Bioorganic & Medicinal Chemistry Letters | Q2709483 |
| P1476 | title | N3-methyl-mafosfamide as a chemically stable, alternative prodrug of mafosfamide | |
| P478 | volume | 8 |
Search more.